Home >> Signaling Pathways >> DNA Damage/DNA Repair

DNA Damage/DNA Repair

  1. Cat.No. Product Name Information
  2. GC26084 XL413 (BMS-863233) XL413 (BMS-863233) is a potent and selective cell division cycle 7 homolog (CDC7) kinase inhibitor with IC50 of 3.4 nM, showing 63-, 12- and 35-fold selectivity over CK2, Pim-1 and pMCM2, respectively. Phase 1/2. XL413 (BMS-863233)  Chemical Structure
  3. GC25996 THZ1 2HCl THZ1 is a covalent CDK7 inhibitor which has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. THZ1 2HCl  Chemical Structure
  4. GC25594 LY3405105 LY3405105 is an orally active CDK7 inhibitor with an IC50 of 92.8 nM. LY3405105 shows potential antineoplastic activity. LY3405105  Chemical Structure
  5. GC25593 LY3143921 hydrate LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor. LY3143921 hydrate  Chemical Structure
  6. GC25552 KT-531 KT-531 (KT531) is a potent, selective HDAC6 inhibitor with IC50 of 8.5 nM, displays 39-fold selectivity over other HDAC isoforms. KT-531  Chemical Structure
  7. GC25372 Elimusertib (BAY-1895344) hydrochloride Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM. Elimusertib (BAY-1895344) hydrochloride  Chemical Structure
  8. GC25139 Biphenyl-4-sulfonyl chloride Biphenyl-4-sulfonyl chloride (p-Phenylbenzenesulfonyl, 4-Phenylbenzenesulfonyl, p-Biphenylsulfonyl) is a HDAC inhibitor with synthetic applications in palladium-catalyzed desulfitative C-arylation. Biphenyl-4-sulfonyl chloride  Chemical Structure
  9. GC68474 Pivanex Pivanex  Chemical Structure
  10. GC68455 CP681301 CP681301  Chemical Structure
  11. GC68448 AOH1160 AOH1160  Chemical Structure
  12. GC68436 L82-G17 L82-G17  Chemical Structure
  13. GC68332 4-Hydroperoxy Cyclophosphamide-d4 4-Hydroperoxy Cyclophosphamide-d4  Chemical Structure
  14. GC68161 5-AIQ 5-AIQ  Chemical Structure
  15. GC68035 PARP10/15-IN-1 PARP10/15-IN-1  Chemical Structure
  16. GC68010 HDAC3-IN-T247 HDAC3-IN-T247  Chemical Structure
  17. GC68006 PARP1-IN-11 PARP1-IN-11  Chemical Structure
  18. GC67990 RPR121056 RPR121056  Chemical Structure
  19. GC67984 Alteminostat Alteminostat  Chemical Structure
  20. GC67970 DD-03-156 DD-03-156  Chemical Structure
  21. GC67963 USP15-IN-1 USP15-IN-1  Chemical Structure
  22. GC67962 Simmiparib Simmiparib  Chemical Structure
  23. GC67960 AVG-233 AVG-233  Chemical Structure
  24. GC67946 Adenine-d1 Adenine-d1  Chemical Structure
  25. GC67915 FT3967385 FT3967385  Chemical Structure
  26. GC67906 OM-153 OM-153  Chemical Structure
  27. GC67886 DC-U4106 DC-U4106  Chemical Structure
  28. GC67876 APE1-IN-1 APE1-IN-1  Chemical Structure
  29. GC67865 RP-6685 RP-6685  Chemical Structure
  30. GC67785 L82 L82  Chemical Structure
  31. GC67775 Casein kinase 1δ-IN-3 Casein kinase 1δ-IN-3  Chemical Structure
  32. GC67716 Mitonafide Mitonafide  Chemical Structure
  33. GC67712 STAMBP-IN-1 STAMBP-IN-1  Chemical Structure
  34. GC67674 CRA-026440 hydrochloride CRA-026440 hydrochloride  Chemical Structure
  35. GC67671 5-Methylcytidine 5′-triphosphate trisodium 5-Methylcytidine 5′-triphosphate trisodium  Chemical Structure
  36. GC52516 Erbstatin A tyrosine kinase inhibitor Erbstatin  Chemical Structure
  37. GC52513 Indolimine-214 A genotoxic gut microbiota metabolite Indolimine-214  Chemical Structure
  38. GC52455 Pixantrone-d8 (maleate) An internal standard for the quantification of pixantrone Pixantrone-d8 (maleate)  Chemical Structure
  39. GC52391 306-O12B-3 An ionizable cationic lipidoid 306-O12B-3  Chemical Structure
  40. GC52351 Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide A biotinylated and citrullinated α-enolase peptide Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide  Chemical Structure
  41. GC52303 Ethyl Mycophenolate A potential impurity found in commercial preparations of mycophenolate mofetil Ethyl Mycophenolate  Chemical Structure
  42. GC67477 Tiazofurin Tiazofurin (NSC 286193) is a synthetic nucleoside analogue with antineoplastic activity. Tiazofurin is anabolized intracellularly to tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH). Tiazofurin also has anti-orthopoxvirus and anti-variola activities. Tiazofurin  Chemical Structure
  43. GC67384 2′-Deoxy-β-L-uridine 2'-Deoxy-β-L-uridine is a nucledside analogue and a specific substrate for the viral enzyme, shows no stereospecificity against herpes simplex 1 (HSV1) thymidine kinase (TK). 2′-Deoxy-β-L-uridine exerts antiviral activity via the interation of 5'-triphosphates with the viral DNA polymerase. 2′-Deoxy-β-L-uridine  Chemical Structure
  44. GC66885 Bz-rC Phosphoramidite Bz-rC Phosphoramidite is a phosphinamide monomer that can be used in the preparation of oligonucleotides. Bz-rC Phosphoramidite  Chemical Structure
  45. GC66713 2'-O-MOE-5-Me-C(Bz) 2'-O-MOE-5-Me-C (Bz) is a nucleotide for the stereoselective synthesis of nucleoside alkyl phosphonates. 2'-O-MOE-5-Me-C(Bz)  Chemical Structure
  46. GC66711 DMTr-LNA-5MeU-3-CED-phosphoramidite DMTr-LNA-5MeU-3-CED-phosphoramidite is a nucleoside derivative. DMTr-LNA-5MeU-3-CED-phosphoramidite  Chemical Structure
  47. GC66659 LNA-A(Bz) amidite LNA-A(Bz) amidite can be used for synthesis of ASOs (antisense oligonucleotides). LNA-A(Bz) amidite  Chemical Structure
  48. GC66658 5-Me-dC(Ac) amidite 5-Me-dC(Ac) amidite is used for synthesizing DNA or RNA. 5-Me-dC(Ac) amidite  Chemical Structure
  49. GC66657 2'-O-MOE-5-Me-rC 2'-O-MOE-5-Me-rC is an active compound. 2'-O-MOE-5-Me-rC can be used for oligonucleotide synthesis. 2'-O-MOE-5-Me-rC  Chemical Structure
  50. GC66656 2'-O-MOE-rC 2'-O-MOE-rC is a 2'-O-MOE modified nucleoside. 2'-O-MOE-rC can be used for synthesis of DNA. 2'-O-MOE-rC  Chemical Structure
  51. GC66655 2'-O,4'-C-Methyleneguanosine 2′-O,4′-C-Methyleneguanosine (LNA-G) is a reverse guanine analogue, where LNA (locked nucleic acid) is a nucleic acid analogue. LNA modification can be used in a variety of applications such as effective binding affinity to complementary sequences and greater nuclease resistance than natural nucleotides, offering great potential for applications in disease diagnosis and research. LNA-G is also available via KOD DNA polymerase, which allows the integration of LNA-G nucleotides into the DNA strand. 2'-O,4'-C-Methyleneguanosine  Chemical Structure
  52. GC66654 2'-O,4'-C-Methylenecytidine 2'-O,4'-C-Methylenecytidine (LNA-C(Bz)) is a bicyclic nucleoside analogue with fixed N-type conformation. 2'-O,4'-C-Methylenecytidine can be used to synthesize oligonucleotides. 2'-O,4'-C-Methylenecytidine forms duplexes with complementary DNA and RNA strands. 2'-O,4'-C-Methylenecytidine  Chemical Structure
  53. GC66652 2'-O-MOE-U 2'-O-MOE-U is a phosphoramidite, can be used for oligonucleotide synthesis. 2'-O-MOE-U  Chemical Structure
  54. GC66651 2'-O,4'-C-Methyleneadenosine 2'-O,4'-C-Methyleneadenosine (LNA-A) is a locked nucleic acid (LNA) and is also an adenosine analog. 2'-O,4'-C-Methyleneadenosine  Chemical Structure
  55. GC66622 L-Guanosine L-Guanosine is the L-configuration of Guanosine . Guanosine is a purine nucleoside with anti-herpesvirus activity. L-Guanosine  Chemical Structure
  56. GC66475 CDK9-IN-10 CDK9-IN-10 is a potent CDK9 inhibitor. CDK9-IN-10 is the ligand for the PROTAC CDK9 degrader-2 (HY-112811). CDK9-IN-10  Chemical Structure
  57. GC66446 LDC4297 hydrochloride LDC4297 hydrochloride is a selective inhibitor of CDK7 with an IC50 value of 0.13 nM. LDC4297 hydrochloride inhibits human cytomegalovirus (HCMV) replication with an EC50 value of 24.5 nM. LDC4297 hydrochloride shows broad antiviral activities to Herpesviridae, Adenoviridae, Poxviridae, Retroviridae and Orthomyxoviridae with EC50 values of 0.02-1.21 μM. LDC4297 hydrochloride can be used for the research of infection. LDC4297 hydrochloride  Chemical Structure
  58. GC66438 USP5-IN-1 USP5-IN-1 (compound 64), a potent deubiquitinase USP5 inhibitor, binds to the USP5 ZnF-UBD with a KD of 2.8 μM. USP5-IN-1 is selective over nine proteins containing structurally similar ZnF-UBD domains. USP5-IN-1 inhibits the USP5 catalytic cleavage of a di-ubiquitin substrate. USP5-IN-1  Chemical Structure
  59. GC66430 Fludarabine triphosphate trisodium Fludarabine triphosphate (F-ara-ATP) trisodium, the active metabolite of Fludarabine (HY-B0069), is a potent, noncompetitive and specific inhibitor of DNA primase, with an IC50 of 2.3 μM and a Ki of 6.1 μM. Fludarabine triphosphate trisodium inhibits DNA synthesis by blocking DNA primase and primer RNA formation. Fludarabine triphosphate trisodium inhibits ribonucleotide reductase and DNA polymerase and ultimately leads to cellular apoptosis. Fludarabine triphosphate trisodium  Chemical Structure
  60. GC66422 Trimethoprim-d9 Trimethoprim-d9 is the deuterium labeled Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for urinary tract infections, Shigellosis and Pneumocystis pneumonia treatment. Trimethoprim-d9  Chemical Structure
  61. GC66387 Lometrexol disodium Lometrexol (DDATHF) disodium, an antipurine antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol disodium can further inhibit de novo purine synthesis, causing abnormal cell proliferation and apoptosis, even cell cycle arrest. Lometrexol disodium has anticancer activity. Lometrexol disodium also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor. Lometrexol disodium  Chemical Structure
  62. GC66325 N2-Acetylguanine N2-Acetylguanine is a C2-modified guanine. N2-Acetylguanine binds GR (guanine-guanine riboswitch) with an Kd value of 300 nM. N2-Acetylguanine modulate transcriptional termination. N2-Acetylguanine has the potential for the research of antimicrobial agent. N2-Acetylguanine  Chemical Structure
  63. GC66210 DMT-2'O-MOE-rG(ib) Phosphoramidite DMT-2'O-MOE-rG(ib) Phosphoramidite (1g), belonging to the amide family of trivalent phosphate H3PO3, is a derivative of nucleotides and guanosine and can be used in the stereochemical synthesis of phosphorothioate oligonucleotides. DMT-2'O-MOE-rG(ib) Phosphoramidite  Chemical Structure
  64. GC66091 2'-O-MOE-5-Me-rU 2'-O-MOE-5-Me-rU is an active compound. 2'-O-MOE-5-Me-rU can be used for oligonucleotide synthesis. 2'-O-MOE-5-Me-rU  Chemical Structure
  65. GC66075 N1-Methylpseudouridine-5′-triphosphate trisodium N1-Methylpseudouridine-5′-triphosphate (1-Methylpseudouridine-5′-triphosphate) trisodium is a nucleobase-modified nucleotide, used for synthesizing mRNA with reduced immunogenicity and improved stability. N1-Methylpseudouridine-5′-triphosphate trisodium  Chemical Structure
  66. GC66060 7-Iodo-2',3'-dideoxy-7-deaza-guanosine 7-Iodo-2',3'-dideoxy-7-deaza-guanosine is a dideoxynucleoside that can be used in DNA synthesis and sequencing reactions. 7-Iodo-2',3'-dideoxy-7-deaza-guanosine  Chemical Structure
  67. GC66058 7-TFA-ap-7-Deaza-dA 7-TFA-ap-7-Deaza-dA is a modified nucleoside. 7-TFA-ap-7-Deaza-dA can be used in the synthesis of deoxyribonucleic acid or nucleic acid. 7-TFA-ap-7-Deaza-dA  Chemical Structure
  68. GC66055 5-Phenylpentan-2-one 5-Phenylpentan-2-one is a potent histone deacetylases (HDACs) inhibitor. 5-Phenylpentan-2-one can be used for urea cycle disorder research. 5-Phenylpentan-2-one  Chemical Structure
  69. GC66052 HDAC-IN-40 HDAC-IN-40 is a potent alkoxyamide-based HDAC inhibitor with Ki values of 60 nM and 30 nM for HDAC2 and HDAC6, respectively. HDAC-IN-40 had antitumor effects. HDAC-IN-40  Chemical Structure
  70. GC66033 Casein kinase 1δ-IN-1 Casein kinase 1δ-IN-1 (compound 822) is an inhibitor of casein kinase 1 delta (CK1δ), exhibits inhibition of greater than 5%. Casein kinase 1δ-IN-1 can be used for neurodegenerative disorders such as Alzheimer's disease research. Casein kinase 1δ-IN-1  Chemical Structure
  71. GC66009 CDK5-IN-3 CDK5-IN-3 (compound 11) is a potent and selective CDK5 inhibitor, with IC50s of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. CDK5-IN-3 can be used for the research of autosomal dominant polycystic kidney disease (ADPKD). CDK5-IN-3  Chemical Structure
  72. GC65997 (S)-LY3177833 hydrate (S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity. (S)-LY3177833 hydrate  Chemical Structure
  73. GC65965 MPT0E028 MPT0E028 is an orally active and selective HDAC inhibitor with IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2 and HDAC6, respectively. MPT0E028 reduces the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma. MPT0E028 has good anticancer activity. MPT0E028  Chemical Structure
  74. GC65939 Indimitecan Indimitecan (LMP776) is a topoisomerase I (Top1) inhibitor with anticancer activities. Indimitecan  Chemical Structure
  75. GC65927 PARP-2-IN-1 PARP-2-IN-1 is a potent and selective PARP-2 inhibitor with an IC50 of 11.5 nM. PARP-2-IN-1  Chemical Structure
  76. GC65907 KSQ-4279 KSQ-4279 (USP1-IN-1, Formula I) is a USP1 and PARP inhibitor (extracted from patent WO2021163530). KSQ-4279  Chemical Structure
  77. GC65899 AZ3391 AZ3391 is a potent inhibitor of PARP. AZ3391 is a quinoxaline derivative. PARP family of enzymes play an important role in a number of cellular processes, such as replication, recombination, chromatin remodeling, and DNA damage repair. AZ3391 has the potential for the research of diseases and conditions occurring in tissues in the central nervous system, such as the brain and spinal cord (extracted from patent WO2021260092A1, compound 23). AZ3391  Chemical Structure
  78. GC65891 PCLX-001 PCLX-001 is an orally acitve, small-molecule, dual N-myristoyltransferase (NMT) inhibitor, with IC50s of 5 nM (NMT1) and 8 nM (NMT2), respectively. PCLX-001 exhibits anti-tumor activity and inhibits early B-cell receptor (BCR) signaling, can be used to B-cell malignancies research. PCLX-001  Chemical Structure
  79. GC65878 Cimpuciclib tosylate Cimpuciclib tosylate is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity. Cimpuciclib tosylate  Chemical Structure
  80. GC65877 (S)-GFB-12811 (S)-GFB-12811 (compound 596) is a potent and selective CDK5 inhibitor, with an IC50 value less than 10 nM. (S)-GFB-12811 can be used in the research of cell cycle progression, neuronal development, tumorigenesis. (S)-GFB-12811  Chemical Structure
  81. GC65675 7-Iodo-7-deaza-2'-deoxyguanosine 7-Iodo-7-deaza-2'-deoxyguanosine (7-Deaza-7-Iodo-2'-deoxyguanosine) is a deoxyguanosine derivative that can be used in DNA synthesis and sequencing reactions. 7-Iodo-7-deaza-2'-deoxyguanosine  Chemical Structure
  82. GC65617 DHFR-IN-3 DHFR-IN-3 is a dihydrofolate reductase (DHFR) inhibitor with the IC50 values of 19 μM and 12 μM in rat liver and P. carinii DHFR, respectively. DHFR-IN-3  Chemical Structure
  83. GC52183 2'-O-Methyl-5-methyluridine 2'-O-Methyl-5-methyluridine  Chemical Structure
  84. GC52175 IQA IQA  Chemical Structure
  85. GC52171 Clindamycin-d3 (hydrochloride) Clindamycin-d3 (hydrochloride) is the deuterium labeled Clindamycin. Clindamycin-d3 (hydrochloride)  Chemical Structure
  86. GC52165 Minosaminomycin Minosaminomycin  Chemical Structure
  87. GC52129 3-Amino-5-hydroxybenzoic Acid 3-Amino-5-hydroxybenzoic Acid  Chemical Structure
  88. GC65577 JH-XVI-178 JH-XVI-178 is a highly potent and selective inhibitor of CDK8/19 that displays low clearance and moderate oral pharmacokinetic properties. JH-XVI-178  Chemical Structure
  89. GC65562 5'-O-DMT-N6-Me-2'-dA 5'-O-DMT-N6-Me-2'-dA is a nucleoside with protective and modification effects. 5'-O-DMT-N6-Me-2'-dA  Chemical Structure
  90. GC65561 N6-Methyl-dA phosphoramidite N6-Methyl-dA phosphoramidite can be used in the synthesis of oligodeoxyribonucleotides. N6-Methyl-dA phosphoramidite  Chemical Structure
  91. GC65551 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine is a bicyclic nucleoside. 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine  Chemical Structure
  92. GC65546 DNMT3A-IN-1 DNMT3A-IN-1 is a potent and selective DNMT3A inhibitor. DNMT3A-IN-1  Chemical Structure
  93. GC65540 eIF4A3-IN-2 eIF4A3-IN-2 is a highly selective and noncompetitive eukaryotic initiation factor 4A-3 (eIF4A3) inhibitor with an IC50 of 110 nM. eIF4A3-IN-2  Chemical Structure
  94. GC65525 7-TFA-ap-7-Deaza-dG 5'-O-TBDMS-dG is a modified nucleoside. 7-TFA-ap-7-Deaza-dG  Chemical Structure
  95. GC65520 5'-DMT-3'-TBDMS-ibu-rG 5'-DMT-3'-TBDMS-ibu-rG is is a modified nucleoside. 5'-DMT-3'-TBDMS-ibu-rG  Chemical Structure
  96. GC65514 ATR inhibitor 1 ATR inhibitor 1 is a ATR inhibitor extracted from patent WO2015187451A1, compound I-l, has a Ki value below 1 ?Μ. ATR inhibitor 1  Chemical Structure
  97. GC65489 2'-F-Bz-dC Phosphoramidite 2'-F-Bz-dC Phosphoramidite can be used in the synthesis of oligoribonucleotides. 2'-F-Bz-dC Phosphoramidite  Chemical Structure
  98. GC65482 5'-O-DMT-N6-ibu-dA 5'-O-DMT-N6-ibu-dA can be used in the synthesis of oligodeoxyribonucleotides. 5'-O-DMT-N6-ibu-dA  Chemical Structure
  99. GC65471 JH-XI-10-02 JH-XI-10-02 is a PROTAC connected by ligands for Cereblon and CDK. JH-XI-10-02 is a highly potent and selective PROTAC CDK8 degrader, with an IC50 of 159 nM. JH-XI-10-02 causes proteasomal degradation, does not affect CDK8 mRNA levels. JH-XI-10-02 shows no effect on CDK19. JH-XI-10-02  Chemical Structure
  100. GC65462 Adenosine 5′-monophosphoramidate sodium Adenosine 5′-monophosphoramidate sodium is an adenosine derivative and can be used as an intermediate for nucleotide synthesis. Adenosine 5′-monophosphoramidate sodium  Chemical Structure
  101. GC65460 HDACs/mTOR Inhibitor 1 HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies, with IC50s of 0.19 nM, 1.8 nM, 1.2 nM and >500 nM for HDAC1, HDAC6, mTOR and PI3Kα, respectively. HDACs/mTOR Inhibitor 1 stimulates cell cycle arrest in G0/G1 phase and induce tumor cell apoptosis with low toxicity in vivo. HDACs/mTOR Inhibitor 1  Chemical Structure

Items 1 to 100 of 1255 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction